Review article: Multiple sclerosis and reproductive risks in women

Reproductive Sciences

Volumn 15, Issue 8, 2008, Pages 755-764

  Argyriou, Andreas A ^a   Makris, Nicolaos ^a  

^a UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

Author keywords

Central nervous system; Delivery; Demyelination; Multiple sclerosis; Pregnancy

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOSPORIN A; ESTRADIOL; ESTRIOL; ESTROGEN; GESTAGEN; GLATIRAMER; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE;

ABORTION; ALLERGIC ENCEPHALOMYELITIS; BREAST FEEDING; CARDIOVASCULAR MALFORMATION; CLINICAL TRIAL; CRANIOFACIAL MALFORMATION; EPIDURAL ANESTHESIA; GASTROINTESTINAL MALFORMATION; GENERAL ANESTHESIA; GESTATION PERIOD; GROWTH RETARDATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMMUNOMODULATION; LIMB DEFECT; MULTIPLE SCLEROSIS; NONHUMAN; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PUERPERIUM; REPRODUCTION; REVIEW; FEMALE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION;

FEMALE; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 54349127408     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108324138     Document Type: Review

References (63)

1. Benedict RH, Bobholz JH Multiple sclerosis. Semin Neurol. 2007 ; 27: 78-85.
2. Ness JM, Chabas D., Sadovnick AD, Pohl D., Banwell B., Weinstock-Guttman B. for the International Pediatric MS Study Group. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007 ; 68 (16 suppl 2). S37 - S45.
3. Desousa EA, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen. 2002 ; 17 (1). 23-29.
4. Polman CH, Reingold SC, Edan G., Filippi M., Hartung HP, Kappos L., Lublin FD, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol. 2005 ; 58: 840-846.
5. Vollmer T. The natural history of relapses in multiple sclerosis. J Neurol Sci. 2007 ; 256 (suppl 1). S5 - S13.
6. Bennett KA Pregnancy and multiple sclerosis. Clin Obstet Gynecol. 2005 ; 48: 38-47.
7. Whitaker JN Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med. 1998 ; 339: 339-340.
8. Mueller BA, Zhang J., Critchlow CW Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol. 2002 ; 186: 446-452.
9. Oksenberg JR, Barcellos LF The complex genetic aetiology of multiple sclerosis. J Neurovirol. 2000 ; 6 (suppl 2). S10 - S14.
10. Kantarci O., Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol. 2006 ; 19: 248-254.
11. Weber F., Fontaine B., Cournu-Rebeix I., et al. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 2008 ; 9: 259-263.
12. Dyment DA, Ebers GC, Sadovnick AD Genetics of multiple sclerosis. Lancet Neurol. 2004 ; 3: 104-110.
13. Ferrero S., Pretta S., Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004 ; 115: 3-9.
14. Orvieto R., Achiron R., Rotstein Z., Noy S., Bar-Hava I., Achiron A. Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol. 1999 ; 82: 191-194.
15. Worthington J., Jones R., Crawford M., Forti A. Pregnancy and multiple sclerosis-a 3-year prospective study. J Neurol. 1994 ; 241: 228-233.
16. Dahl J., Myhr KM, Daltveit AK, Gilhus NE Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol. 2008 ; 255: 623-627.
17. Sadovnick AD, Eisen K., Hashimoto SA, et al. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol. 1994 ; 51: 1120-1124.
18. De Las Heras V., De Andrés C., Téllez N., Tintoré M. for the EMPATIE Study Group. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler. 2007 ; 13: 981-984.
19. Durufle A., Nicolas B., Petrilli S., et al. Effects of pregnancy and childbirth on the incidence of urinary disorders in multiple sclerosis. Clin Exp Obstet Gynecol. 2006 ; 33: 215-218.
20. Webb JA, Thomsen HS, Morcos SK The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005 ; 15: 1234-1240. for the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR).
21. Paavilainen T., Kurki T., Parkkola R., et al. Magnetic resonance imaging of the brain used to detect early postpartum activation of multiple sclerosis. Eur J Neurol. 2007 ; 14: 1216-1221.
22. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Guidelines for diagnostic imaging during pregnancy. ACOG Committee Opinion No. 158. Washington, DC: ACOG ; 1995.
23. Bernardi S., Grasso MG, Bertollini R., Orzi F., Fieschi C. The influence of pregnancy on relapses in multiple sclerosis: a cohort study. Acta Neurol Scand. 1991 ; 84: 403-406.
24. Confavreux C., Hutchinson M., Hours M., et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998 ; 339: 285-291.
25. Saraste M., Väisänen S., Alanen A., Airas L., and the Finnish Multiple Sclerosis and Pregnancy Study Group. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend Med. 2007 ; 4: 45-55.
26. Airas L., Saraste M., Rinta S., Elovaara I., Huang YH, Wiendl H., and the Finnish Multiple Sclerosis and Pregnancy Study Group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin Exp Immunol. 2008 ; 151: 235-243.
27. Doria A., Iaccarino L., Arienti S., et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006 ; 22: 234-241.
28. Al-Shammri S., Rawoot P., Azizieh F., et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 2004 ; 222: 21-27.
29. Zhu WH, Lu CZ, Huang YM, Link H., Xiao BG A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells. Mult Scler. 2007 ; 13: 33-40.
30. Gregg C., Shikar V., Larsen P., et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci. 2007 ; 27: 1812-1823.
31. Voskuhl RR Hormone-based therapies in MS. Int MS J. 2003 ; 10: 60-66.
32. Guthrie TC, Nelson DA Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci. 1995 ; 129: 1-8.
33. Bader AM, Hunt CO, Datta S., et al. Anesthesia for obstetric patients with multiple sclerosis. J Clin Anesth. 1988 ; 1: 21-24.
34. Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr Opin. Anaesthesiol. # 2002 ; 15: 365-370.
35. Crawford JS Epidural analgesia for patients with chronic neurological disease. Anesth Analg. 1983 ; 62: 621-622.
36. Capdeville M., Hoyt MR Anesthesia and analgesia in the obstetric population with multiple sclerosis. A retrospective review. Anesthesiology. 1994 ; 81: 1173.
37. Jones RM, Healy TE Anesthesia and demyelinating disease. Anaesthesia. 1980 ; 35: 879-884.
38. Vercauteren M., Heytens L. Anaesthetic considerations for patients with a pre-existing neurological deficit: are neuraxial techniques safe? Acta Anaesthesiol. Scand. 2007 ; 51: 831-838.
39. Cooperman LH Succinylcholine induced hyperkalemia in neuromuscular disease. JAMA. 1970 ; 213: 1867-1871.
40. Drake E., Drake M., Bird J., Russell R. Obstetric regional blocks for women with multiple sclerosis: a survey of UK experience. Int J Obstet Anesth. 2006 ; 15: 115-123.
41. Rayburn WF Glucocorticoid therapy for rheumatic diseases: maternal, fetal, and breast-feeding considerations. Am J Reprod Immunol. 1992 ; 28: 138-140.
42. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 ; 108: 776-789.
43. Nguyen C., Duhl AJ, Escallon CS, Blakemore KJ Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester. Obstet Gynecol. 2002 ; 99: 599-602.
44. Bar Oz B., Hackman R., Einarson T., Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001 ; 71: 1051-1055.
45. De Santis M., Straface G., Cavaliere AF, Rosati P., Batocchi AP, Caruso A. The first case of mitoxantrone exposure in early pregnancy. Neurotoxicology. 2007 ; 28: 696-697.
46. Ostensen M. Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol. 1992 ; 28: 148-152.
47. Avonex (Interferon beta 1-a). Biogen, Canada, 1998. Product monograph.
48. Boskovic R., Wide R., Wolpin J., Bauer DJ, Koren G. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology. 2005 ; 65: 807-811.
49. Sandberg-Wollheim M., Frank D., Goodwin TM, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005 ; 65: 802-806.
50. Achiron A., Kishner I., Dolev M., et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol. 2004 ; 251: 1133-1137.
51. Nelson LM, Franklin GM, Jones MC Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA. 1988 ; 259: 3441-3443.
52. Vukusic S., Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin Neurol Neurosurg. 2006 ; 108: 266-270.
53. Vukusic S., Hutchinson M., Hours M., et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004 ; 127: 1353-1360.
54. Roullet E., Verdier-Taillefer MH, Amarenco P., Gharbi G., Alperovitch A., Marteau R. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry. 1993 ; 56: 1062-1065.
55. Hellwig K., Brune N., Haghikia A., et al. Reproductive counselling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand. 2008 ; 118: 24-28.
56. De Seze J., Chapelotte M., Delalande S., Ferriby D., Stojkovic T., Vermersch P. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler. 2004 ; 10: 596-597.
57. El-Etr M., Vukusic S., Gignoux L., et al. Steroid hormones in multiple sclerosis. J Neurol Sci. 2005 ; 233: 49-54.
58. Antonio M., Patrizia F., Ilaria I., Paolo F. A rational approach on the use of sex steroids in multiple sclerosis. Recent Patents CNS Drug Discov. 2008 ; 3: 34-39.
59. Palaszynski KM, Liu H., Loo KK, Voskuhl RR Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neuroimmunol. 2004 ; 149: 84-89.
60. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452.
61. Weinshenker BG, Hader W., Carriere W., Baskerville J., Ebers GC The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology. 1989 ; 39: 1438-1440.
62. Runmarker B., Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain. 1995 ; 118: 253-261.
63. Verdru P., Theys P., D'Hooghe MB, Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg. 1994 ; 96: 38-41.